GLP-1 drugs may lower odds of developing substance use disorders

A 2026 study suggests that people who take GLP-1 drugs—prescribed for diabetes and weight loss—are less likely to develop a substance use disorder. Among people who already have addiction, use of a GLP-1 was linked with fewer complications such as overdose and death.